Although the World Health Organization has been removed as a direct stakeholder in potential discussions on developing a global biomedical R&D treaty under the global strategy and action plan, other avenues are open for the treaty, member states of the World Health Assembly (WHA) heard today.
The R&D treaty is just one of the ideas encompassed in the global strategy and plan of action on public health, innovation and intellectual property, which came about as a result of the IGWG talks